Identification and Characterization of an Irreversible Inhibitor of CDK2.
Anscombe, E., Meschini, E., Mora-Vidal, R., Martin, M.P., Staunton, D., Geitmann, M., Danielson, U.H., Stanley, W.A., Wang, L.Z., Reuillon, T., Golding, B.T., Cano, C., Newell, D.R., Noble, M.E., Wedge, S.R., Endicott, J.A., Griffin, R.J.(2015) Chem.Biol. 22: 1159-1164
- PubMed: 26320860 
- DOI: 10.1016/j.chembiol.2015.07.018
- PubMed Abstract: 
Irreversible inhibitors that modify cysteine or lysine residues within a protein kinase ATP binding site offer, through their distinctive mode of action, an alternative to ATP-competitive agents. 4-((6-(Cyclohexylmethoxy)-9H-purin-2-yl)amino)benzenes ...